It is just a nootropic drug invented in 1996 by a team working for Merck, Sharp and Dohme, that was the 1st compound produced which acts as being a subtype-selective inverse agonist in the α5 subtype from the benzodiazepine binding web-site on the GABAA receptor. mydrugbuddy reported: Fasci